Toward Concurrent Testing for Somatic and Germline Variants in Cancer Patients

Workflow of tumor–germline sequencing. Germline variant calls are subtracted from tumor variant calls to determine the somatic variants in the tumor. The germline variants for selected genes associated with cancer susceptibility are then evaluated. Pathogenic and likely pathogenic germline variants are reported to the patient through the clinical genetics service. VUS, variant of uncertain significance.